期刊文献+

胱抑素C对早期诊断肝炎后肝硬化患者肾功能损害的临床研究 被引量:3

Diagnostic Value of Cystatin C for Early Detection of Renal Injury in Patients with Posthepatitis Cirrhosis
下载PDF
导出
摘要 目的探讨血清胱抑素C(Cys C)检测对早期诊断肝炎后肝硬化患者肾功能损害的意义。方法 38例肝炎后肝硬化患者按照Child-Pugh分级分为三组(A级10例、B级14例、C级14例),另选20例健康者为对照组,测定四组患者的血尿素氮(BUN)、24 h肌酐清除率(Ccr)、血清肌酐(SCr)和血清Cys C水平,并进行比较。结果随着Child-Pugh分级的上升,Ccr逐渐下降,SCr和Cys C逐渐上升(P<0.05);Cys C、SCr均与Ccr有着显著的负相关性(P<0.01),而Cys C的相关系数较高。结论 Cys C能更早期发现肝炎后肝硬化患者肾功能损害,常规监测肝炎后肝硬化患者的Cys C水平,对防治肝肾综合征的发生具有积极意义。 Objective To investigate the diagnostic value of cystatin C ( Cys C) for early detection of re- nal injury in patients with posthepatitis cirrhosis. Methods 38 cases of liver cirrhosis patients according to Child-Pugh classification were divided into three groups( class A 10 cases, class B 14 cases, class C 14 ca- ses) ;another 20 healthy people were selected as control group, blood urea nitrogen (BUN), 24 h creatinine clearance rate( Ccr), serum creatinine(SCr) and serum Cys C levels of the four groups were tested. Results With the rise in Child-Pugh classification, Ccr decreased and SCr and Cys C increased gradually( P 〈 0.05 ) ; Cys C and SCr were both significantly inverse correlated with Ccr( P 〈 0. 01 ), while the Cys C correlation co- efficient was higher. Conclusion Cystatin C is a more sensitive marker of renal injury in posthepatitis cir- rhosis. Routine monitoring of Cys C level in patients with posthepatitis cirrhosis could contribute to the pre- vention and treatment of hepatorenal syndrome.
出处 《医学综述》 2012年第17期2878-2880,共3页 Medical Recapitulate
关键词 肝炎后肝硬化 肾功能损害 胱抑素C Posthepatitis cirrhosis Renal injury Cystatin C
  • 相关文献

参考文献9

  • 1Song S, Meyer M,TUrk TR,et al. Serum cystatin C in mouse models: a reliable and precise marker for renal function and superior to serum creatin!ne[ J]. Nepal Dial Transplant,2009,24 ( 4 ): 1157-l 161.
  • 2陆再英,钎南山j内科学[M].17版:北景:人百卫叠出砬社,2008:452-453.
  • 3Stevens LA, Coresh J, Greene T, et al. Assessing kidney function-- measured and estimated glomerular filtration rate [ J ]. N Engl J Med,2006,354(23) :2473-2483.
  • 4Filler G, Priem F, Vollmer I, et al. Diagnostic sensitivity of serum cystatin for impaired glomerular filtration rate [ J ]. Pediatr Nephrol, 1999,13(6) :501-505.
  • 5孙艳虹,姜傥,曾智杰,高玲.血清半胱氨酸蛋白酶抑制剂C与血肌酐的匹配研究[J].中华肾脏病杂志,2008,24(8):592-593. 被引量:5
  • 6Mccormick PA, Donnelly C. Management of hepatorenal syndrome [J]. Pharmacol Ther,2008,119( 1 ) :1-6.
  • 7Guevara M, Arroyo VI Hepatorenal syndrome [J]. Expert Opin Phm'- macother, 2011,12 ( 9 ) : 1405-1417.
  • 8Samyn M, Cheeseman P, Bevis L, et al. Cystatin C, an easy and reli- able marker for assessment of renal dysfunction in children with liver disease and after liver transplantation [ J ]. Liver Transpl, 2005,11 (3) :344-349.
  • 9lSge'U, Gerhardt T, Stoffel-Wagner B, et al. Calculation of glomeru- lar filtration rate based on cystatin C in cirrhotic patients [ J ]. Neph- rol Dial Transplant,2006,21 ( 3 ) : 660-664.

二级参考文献5

  • 1孙艳虹,曾智杰,姜傥,高玲,罗美如,范敏珊.血清半胱氨酸蛋白酶抑制剂C在肾病患者肾功能评估中的应用[J].中华肾脏病杂志,2006,22(8):503-504. 被引量:36
  • 2Madero M, Sarnak MJ, Stevens LA. Serum cystatin C as a marker of glomerular filtration rate. Curr Opin Nephrol Hypertens, 2006,15:610-616.
  • 3Sambasivan AS, Lepage N, Filler G. Cystatin C intrapatient variability in children with chronic kidney disease is less than serum creatinine. Clin Chem, 2005,51:2215-2216.
  • 4Zaffanello M, Franchini M, Fanos V. Is serum Cystatin-C a suitable marker of renal function in children? Ann Clin Lab Sci, 2007,37:233-240.
  • 5姚少羽 孙艳虹 曾智杰 等.血清(浆)半胱氨酸蛋白酶抑制剂C与血肌酐之间的匹配研究[J].中国医学检验杂志,2007,8:89-92.

共引文献4

同被引文献42

  • 1王红练.血清胱抑素c在肾脏疾病中的临床价值[J].现代预防学,2012,39(15):3915-3916.
  • 2Song S,Meyer M,Turk TR. Serum Cystatin C in mouse models:a reliable and precise marker for renal function and superior to serum screatinine[J].{H}Nephrology Dialysis Transplantation,2009,(04):1157-1161.
  • 3Arroyo V,Fernandez J,Ginès P. Pathogenesis and treatmentof hepatorenal syndrome[J].{H}Seminars in Liver Disease,2008,(01):81-95.
  • 4Stevens LA,Coresh J,Greene T. Assessing kidney function measured and estimated glomerular filtration rate[J].{H}New England Journal of Medicine,2006,(23):2473-2483.
  • 5Lamb EJ,Tomson SCR,Roderick PJ. Esti-mating kidney function in adults using formulae[J].{H}Annals of Clinical Biochemistry,2005,(05):321-345.
  • 6Adiyanti SS,Loho T. Acute kidney injury (AKI) biomarker[J].Acta Med Indones,2012,(03):246-255.
  • 7Ahn HS,Kim YS,Kim SG. Cystatin C is a good predictor of hepatorenal syndrome and survival in patients with cirrhosis who have normal serum creatinine levels[J].{H}Hepato-Gastroenterology,2012,(116):1168-1173.
  • 8徐幼飞,王小英.血清胱抑素C在肝硬化失代偿期测定的价值[J].浙江预防医学,2009,21(8):88-89. 被引量:6
  • 9唐红梅(综述),姜振伟(综述,廖国林(审校).胱抑素C的临床应用[J].国际检验医学杂志,2011,32(2):216-218. 被引量:56
  • 10杨雪,邱春华.血清胱抑素C在肝硬化患者肝功能评价中的意义[J].中华实用诊断与治疗杂志,2011,25(3):248-250. 被引量:11

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部